German China India

News

Wuxi STA and Dizal Pharmaceutical Collaborate for CMC Development

China: Pharma Partnership

Wuxi STA and Dizal Pharmaceutical Collaborate for CMC Development

22/05/2019 - Under the agreement, Wuxi STA will become the preferred CDMO partner of Dizal Pharmaceutical for the production of GMP. With this, Wuxi STA will provide integrated CMC process research and manufacturing services from API to drug product. read...

The Top 10 Largest Pharmaceutical Mergers in History

Update: Pharmaceutical Mergers and Acquisitions

The Top 10 Largest Pharmaceutical Mergers in History

17/05/2019 - The pharmaceutical industry is under pressure. The sales and profits of the pharmaceutical giants have been declining for years. As a way out of this misery, takeovers and mergers seem to be a tried and tested means. PharmaTEC and PROCESS summarise the largest deals in the history of the industry for you. read...

Boehringer Ingelheim Collaborates with Start Ups for R&D in Healthcare

Germany: Digital Transformation

Boehringer Ingelheim Collaborates with Start Ups for R&D in Healthcare

15/05/2019 - Boehringer Ingelheim is making use of digital technologies to improve healthcare solutions. The company’s pilot project with start-up Sound Talks enabled to prevent diseases among farm animals. read...

more
New Columns, Screening Service for Enantioseparation of Chiral Substances

Chiral Stationary Phases

New Columns, Screening Service for Enantioseparation of Chiral Substances

15/05/2019 - Knauer introduces three new chiral stationary phases (CSPs) that are typically applied in production or quality control of pharmaceuticals with chiral active ingredients. To select the optimal chiral column the Berlin based lab instruments manufacturer also offers a screening service. read...

Bayer Breaks Ground for New Cell Culture Technology Center in California

USA: Engineering Services

Bayer Breaks Ground for New Cell Culture Technology Center in California

12/05/2019 - Fluor announced that a groundbreaking event was held for Bayer’s first-of-a-kind cell culture technology center in Berkeley, California. The engineering company is providing a single point of responsibility for engineering, procurement, construction management and commissioning, qualification and validation of the facility that will produce oncology and other therapeutics. read...

Articles

Optimal Sizing of Pellets

Plansifters

Optimal Sizing of Pellets

10/05/2019 - Sifting machines guarantee high quality of pharmaceutical productions as they size pills. But pharmaceutical manufacturers require for the sizing process not only high throughput. Sifters need to fulfill hygienic and explosion protection requirements. read...

Handling Systems

Handling at its Best

Integrated End-to-end Solution

Enter the Integrated All-in-One Solution For The Lab

more

NEWS

Pfizer Acquires Biotech Company Therachon

USA: Expansion of Rare Disease Portfolio

Pfizer Acquires Biotech Company Therachon

Pfizer has entered into a definitive agreement to acquire all the shares of Therachon, a privately-held clinical-stage biotechnology company focused on rare diseases. Under the terms of the agreement, the US-company will pay $ 340 million upfront with an additional $ 470 million in additional payments contingent. read...

Astra Zeneca Partners with Benevolent AI for Drug Discovery

United Kingdom: Artificial Intelligence

Astra Zeneca Partners with Benevolent AI for Drug Discovery

Under the deal, Astra Zeneca will utilise new age concepts such as machine learning and artificial intelligence to explore potential new drugs for chronic kidney disease and idiopathic pulmonary fibrosis. read...

International Fine and Speciality Chemicals Industry to Meet in Basel

Switzerland: Chemspec Europe

International Fine and Speciality Chemicals Industry to Meet in Basel

Preparations for the 34th edition of Chemspec Europe are well under way. From June 26 to 27, 2019, the International Exhibition for Fine and Speciality Chemicals provides a platform to explore bespoke solutions, new approaches and innovative substances as well as to discuss the latest market trends, technical innovations, business opportunities and regulatory issues in a rapidly changing market. read...